Reynolds Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,900
Closed -$223K 142
2015
Q4
$223K Buy
+2,900
New +$218K 0.24% 119
2015
Q3
Sell
-6,707
Closed -$497K 178
2015
Q2
$497K Hold
6,707
0.49% 62
2015
Q1
$523K Buy
6,707
+407
+6% +$30.8K 0.46% 61
2014
Q4
$455K Buy
+6,300
New +$438K 0.38% 87
2014
Q3
Sell
-4,900
Closed -$312K 268
2014
Q2
$312K Buy
4,900
+500
+11% +$30.4K 0.21% 196
2014
Q1
$271K Buy
+4,400
New +$256K 0.18% 258
2013
Q3
Sell
-5,700
Closed -$294K 446
2013
Q2
$294K Buy
+5,700
New +$282K 0.22% 192

Other funds holding MDT

Reynolds Capital Management's MDT Position: Q1 2016 in Review

Reynolds Capital Management sold out of Medtronic (MDT) in Q1 2016, closing a stake of 2,900 shares — an estimated $223K sold.

Reynolds Capital Management first reported a position in MDT in Q2 2013 and held it in 7 quarters. The position peaked at $523K in Q1 2015. 1,241 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

  • Reynolds Capital Management reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
  • Reynolds Capital Management sold 2,900 Medtronic shares in Q1 2016, an estimated $223K.
  • Reynolds Capital Management first reported a position in Medtronic in Q2 2013 and held it in 7 quarters.
  • Reynolds Capital Management's Medtronic position peaked at $523K in Q1 2015.
  • 1,241 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.